Balazs Hegedus

University Hospital Essen

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Sebastian Reuter

Head of Laboratory

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

Fabian D. Mairinger

University Hospital Essen

GERMANY

View details

Jeremias Wohlschlaeger

Head of Department

GERMANY

View details

Gregor Zaun

University Hospital Essen

GERMANY

View details

Balazs Dome

Medical University of Vienna

AUSTRIA

View details

Michael Wessolly

University Hospital Essen

GERMANY

View details

Michael Grusch

Assoc. Prof.

Medical University of Vienna

AUSTRIA

View details

Halime Kalkavan

University Hospital Essen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Balazs Hegedus

Research Interests

Explore related searches

Contact this professor

Articles (10)

BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK

One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy

TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy

Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis

Early Detection of Lung Cancer using small RNAs.

LA-ICP-MS analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma.

Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow.

Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients

Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer.

The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer

Collaborators (8)

Sebastian Reuter

Fabian D. Mairinger

Jeremias Wohlschlaeger

Gregor Zaun

Balazs Dome

Michael Wessolly

Michael Grusch

Halime Kalkavan

Make your next move.